Invited Speakers
  • Ju-Yang Jung
    Ajou Univ.
    Korea
  • JU-YANG JUNG is a Korean rheumatologist who works in Ajou University School of Medicine as a clinician and immunologic researcher. She had published several articles, which revealed clinical characteristics and promising biomarkers for systemic lupus erythematosus (SLE) and adult onset- Still’s disease during 14 years. Her recent research is focusing on the mechanism of foam cell formation through inflammatory response and the complications of autoimmune diseases including SLE, rheumatoid arthritis, and ankylosing spondylitis. She is working in the Public Relations and the Legal Ethics Committee in Korean College of Rheumatology.
    • Date Time Room Session Title Lecture Title
    May 14 10:30-11:00 Room 1 (3F) Year in Review Sjögren's Disease
    May 14 16:00-16:10 Room 2 (3F) Free Paper Session 2_SLE & Antiphospholipid Syndrome and Sjögren's Syndrome (KO-013) S100A4 and S100A7 as Markers of Immune Activation in Sjögren’s Syndrome
    May 15 08:00-09:00 Room 2 (3F) Breakfast Symposium 2 [Pfizer & Hanlim MS] The Role of Xeljanz As First Approved JAK, Broaden Indications, and Over 10-Year Experience in Korea
    May 15 13:50-14:00 Room 2 (3F) Free Paper Session 6_Rheumatoid Arthritis (I) (KO-049) Comparison of Clinical Characteristics and Drug Survivals of Biologic/targeted Synthetic DMARDs between Elderly and Non-elderly D2T-RA Patients: Data from KOBIO Registry